|
|
| Dr. Morris was invited to join the faculty of the University of Maryland School of Medicine in 1984, where he is now Professor of Medicine and Professor of Epidemiology and Preventive Medicine. He has authored 19 textbook chapters and 127 articles in peer reviewed journals, with continuous federal grant funding since 1984; his scholarly contributions were recognized by election to the American Society for Clinical Investigation in 1996. He has served on three National Academy of Sciences expert committees dealing with food safety, and, from 1994-1996, worked with the Food Safety Inspection Service, U.S. Department of Agriculture, on the first major revision of food safety regulations since 1906. During this time he served as Director of the Epidemiology and Emergency Response Program, FSIS, and was the first Deputy FSIS Administrator for Public Health and Science. Dr. Morris created and now heads the Division of Hospital Epidemiology in the Department of Medicine, University of Maryland School of Medicine. Dr. Morris has a strong interest in the area of emerging pathogens, including work with multi-antibiotic resistant bacteria. He serves as co-PI on the CDC Emerging Infections Program sentinel surveillance site in the Baltimore metropolitan area. In addition, Dr. Morris and his team study the emergence and spread of tuberculosis within acute care hospitals and nursing homes as part of the Maryland Infection Control Network; they also are working to identify and track the spread of multiresistant bacteria in hospitals in the University of Maryland Medical System and VA Maryland Health Care System. In addition to the above projects, Dr. Morris and his team are conducting genetic studies to determine the (i) basis for the emergence of vancomycin (antibiotic) resistance in enterococci, and (ii) mechanisms underlying the exchange of critical genes in Vibrio species and other bacterial pathogens, including Yersinia and Aeromonas. Dr. Morris and his colleagues are also exploring novel treatment strategies (including bacteriophages) for multiresistant bacterial pathogens. Dr. Morris in collaboration with many researchers at the University of Maryland School of Medicine conducted studies on the human health effects associated with Pfiesteria, and is the PI on a program grant from the NIH to study the emergence and biological characteristics of this pathogen. Dr. Morris has been/is a PI or co-PI on various grants and contracts from following funding sources and agencies:
National Institutes of Health (NIH): NIAID, NIEHS |
Website by Glenridge Healthcare Solutions
Copyright © 2000, 2001, 2002, 2003, 2004, 2005 Intralytix, Inc.
|
Dr. Morris received his BA from Rice University in
Houston in 1973, and his M.D. degree and a master's degree in public
health and tropical medicine from Tulane University, New Orleans, in 1977.
His residency training in internal medicine was at the University of Texas
Southwestern in Dallas and Emory University in Atlanta. He served as
an Epidemic Intelligence Service Officer at the Centers for Disease
Control in Atlanta, and then came to the University of Maryland School of
Medicine for subspecialty training in infectious diseases. He is
board certified in both internal medicine and infectious diseases.